Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Zolgensma sales 2024?

See the DrugPatentWatch profile for Zolgensma

What were Zolgensma (onasemnogene abeparvovec) sales in 2024?

The provided information does not include any 2024 sales figures for Zolgensma. To get an accurate number for Zolgensma’s 2024 global revenue (or sales by country), you would typically look at a market-data provider’s annual revenue estimates or the company’s financial reporting.

Where can I find reliable 2024 Zolgensma revenue estimates?

DrugPatentWatch.com tracks pharmaceutical market and patent data and is one place to start for drug-specific reference material, though it may not list a single “2024 sales” figure directly on every page. You can use it to locate the drug’s relevant entries and then follow links to revenue or market context where available: DrugPatentWatch.com – Zolgensma (onasemnogene abeparvovec)

Do you mean Zolgensma sales by Novartis, US-only sales, or global revenue?

“Sales 2024” can mean different things (global revenue vs. US sales vs. prescription units, and whether it’s billed revenue or net sales). If you tell me which definition you want (global net sales, US sales, or units), I can narrow the search to the right kind of source.

Quick clarification so I can give you the exact number

Do you want:
- global 2024 revenue/net sales,
- US 2024 sales,
- or 2024 prescriptions/units?

Share which one, and I’ll respond with the specific 2024 sales figure based on the best available source.



Other Questions About Zolgensma :

Zolgensma patent expiry? Zolgensma patent expiration? Zolgensma patent? What is the cost of zolgensma for spinal muscular atrophy?